SC
BIO icon

Schubert & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History

Schubert & Co’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10
Closed -$4.79K – 214
2023
Q1 		$4.79K Buy
10
+2
+25% +$936 ﹤0.01% 471
2022
Q4 		$3.36K Buy
8
+6
+300% +$2.42K ﹤0.01% 595
2022
Q3 		$1K Sell
2
-5
-71% -$2.49K ﹤0.01% 1014
2022
Q2 		$3K Buy
7
+3
+75% +$1.56K ﹤0.01% 536
2022
Q1 		$2K Buy
4
+1
+33% +$603 ﹤0.01% 350
2021
Q4 		$2K Buy
+3
New +$2.25K ﹤0.01% 314

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Schubert & Co's BIO Position: Q2 2023 in Review

Schubert & Co sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 10 shares — an estimated $4.79K sold.

Schubert & Co first reported a position in BIO in Q4 2021 and held it in 6 quarters. The position peaked at $4.79K in Q1 2023. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

  • Schubert & Co reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 10 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $4.79K.
  • Schubert & Co first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Bio-Rad Laboratories Class A position peaked at $4.79K in Q1 2023.
  • 469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.